Correction to: Nature Cardiovascular Research https://doi.org/10.1038/s44161-023-00278-y. Published online 8 June 2023.
In the version of this article initially published, a protein (pMAPKAPK2) was misspelled in Fig. 1 and Extended Data Fig. 7; a colored box for “AKT” was missing from the second column of regulators in Fig. 5a; Extended Data Fig. 2f was missing a header above the color key; and typographical errors (extraneous citations to refs. 1, 3 and 5) were present in the “Analysis of RNA-seq data from saracatinib-treated tissue” section of Methods. In addition, the Reporting Summary and the legends for Supplementary Figs. 5 and 8 were outdated versions. The errors have been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Amadori, L., Calcagno, C., Fernandez, D.M. et al. Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis. Nat Cardiovasc Res 2, 793 (2023). https://doi.org/10.1038/s44161-023-00310-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-023-00310-1
